248 related articles for article (PubMed ID: 30376852)
1. The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease.
Comhair SAA; Bochenek G; Baicker-McKee S; Wang Z; Stachura T; Sanak M; Hammel JP; Hazen SL; Erzurum SC; Nizankowska-Mogilnicka E
Respir Res; 2018 Oct; 19(1):210. PubMed ID: 30376852
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma.
Bochenek G; Stachura T; Szafraniec K; Plutecka H; Sanak M; Nizankowska-Mogilnicka E; Sladek K
J Allergy Clin Immunol Pract; 2018; 6(2):528-535. PubMed ID: 28888846
[TBL] [Abstract][Full Text] [Related]
3. Urine Leukotriene E4: Implications as a Biomarker in Chronic Rhinosinusitis.
Choby G; Low CM; Levy JM; Stokken JK; Pinheiro-Neto C; Bartemes K; Marino M; Han JK; Divekar R; O'Brien EK; Lal D
Otolaryngol Head Neck Surg; 2022 Feb; 166(2):224-232. PubMed ID: 33973823
[TBL] [Abstract][Full Text] [Related]
4. Elevated Urine Leukotriene E4 Is Associated With Worse Objective Markers in Nasal Polyposis Patients.
Choby G; O'Brien EK; Smith A; Barnes J; Hagan J; Stokken JK; Strumpf A; Mattos JL; Payne SC; Divekar R
Laryngoscope; 2021 May; 131(5):961-966. PubMed ID: 33001452
[TBL] [Abstract][Full Text] [Related]
5. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease.
Mitsui C; Kajiwara K; Hayashi H; Ito J; Mita H; Ono E; Higashi N; Fukutomi Y; Sekiya K; Tsuburai T; Akiyama K; Yamamoto K; Taniguchi M
J Allergy Clin Immunol; 2016 Feb; 137(2):400-11. PubMed ID: 26194538
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcomes of aspirin-exacerbated respiratory disease: Real-world data from an adult asthma cohort.
Lee Y; Kim C; Lee E; Lee HY; Woo SD; You SC; Park RW; Park HS
Clin Exp Allergy; 2023 Sep; 53(9):941-950. PubMed ID: 37332228
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E
Mastalerz L; Tyrak KE; Ignacak M; Konduracka E; Mejza F; Ćmiel A; Buczek M; Kot A; Oleś K; Sanak M
Allergy; 2019 May; 74(5):922-932. PubMed ID: 30446997
[TBL] [Abstract][Full Text] [Related]
9. Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD.
Shin S; Park JS; Kim YJ; Oh T; An S; Park CS
Mol Genet Genomics; 2012 May; 287(5):361-71. PubMed ID: 22457146
[TBL] [Abstract][Full Text] [Related]
10. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
Bochenek G; Kuschill-Dziurda J; Szafraniec K; Plutecka H; Szczeklik A; Nizankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Jan; 133(1):98-103.e1-6. PubMed ID: 23993879
[TBL] [Abstract][Full Text] [Related]
11. Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease.
Choi Y; Sim S; Lee DH; Lee HR; Ban GY; Shin YS; Kim YK; Park HS
PLoS One; 2021; 16(8):e0256237. PubMed ID: 34437574
[TBL] [Abstract][Full Text] [Related]
12. Incidence of aspirin hypersensitivity in patients with chronic rhinosinusitis and diagnostic value of urinary leukotriene E4.
Celejewska-Wójcik N; Mastalerz L; Wójcik K; Nieckarz R; Januszek R; Hartwich P; Szaleniec J; Hydzik-Sobocińska K; Oleś K; Cybulska A; Stręk P; Sanak M
Pol Arch Med Wewn; 2012; 122(9):422-7. PubMed ID: 22814420
[TBL] [Abstract][Full Text] [Related]
13. Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease.
Trinh HKT; Pham DL; Choi Y; Kim HM; Kim SH; Park HS
Clin Exp Allergy; 2018 Nov; 48(11):1464-1473. PubMed ID: 30126026
[TBL] [Abstract][Full Text] [Related]
14. Association of serum periostin with aspirin-exacerbated respiratory disease.
Kim MA; Izuhara K; Ohta S; Ono J; Yoon MK; Ban GY; Yoo HS; Shin YS; Ye YM; Nahm DH; Park HS
Ann Allergy Asthma Immunol; 2014 Sep; 113(3):314-20. PubMed ID: 25037608
[TBL] [Abstract][Full Text] [Related]
15. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
Ledford DK; Wenzel SE; Lockey RF
J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease.
Ban GY; Cho K; Kim SH; Yoon MK; Kim JH; Lee HY; Shin YS; Ye YM; Cho JY; Park HS
Clin Exp Allergy; 2017 Jan; 47(1):37-47. PubMed ID: 27533637
[TBL] [Abstract][Full Text] [Related]
17. Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.
Buchheit KM; Lewis E; Gakpo D; Hacker J; Sohail A; Taliaferro F; Berreondo Giron E; Asare C; Vukovic M; Bensko JC; Dwyer DF; Shalek AK; Ordovas-Montanes J; Laidlaw TM
J Allergy Clin Immunol; 2021 Aug; 148(2):574-584. PubMed ID: 34144111
[TBL] [Abstract][Full Text] [Related]
18. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.
Buchheit KM; Cahill KN; Katz HR; Murphy KC; Feng C; Lee-Sarwar K; Lai J; Bhattacharyya N; Israel E; Boyce JA; Laidlaw TM
J Allergy Clin Immunol; 2016 May; 137(5):1566-1576.e5. PubMed ID: 26691435
[TBL] [Abstract][Full Text] [Related]
19. Surfactant protein D alleviates eosinophil-mediated airway inflammation and remodeling in patients with aspirin-exacerbated respiratory disease.
Choi Y; Lee DH; Trinh HKT; Ban GY; Park HK; Shin YS; Kim SH; Park HS
Allergy; 2019 Jan; 74(1):78-88. PubMed ID: 29663427
[TBL] [Abstract][Full Text] [Related]
20. Urinary Leukotriene E4 as a Biomarker in NSAID-Exacerbated Respiratory Disease (N-ERD): a Systematic Review and Meta-analysis.
Marquette M; Tailor BV; Calder PC; Curtis PJ; Loke Y; Wilson AM
Curr Allergy Asthma Rep; 2022 Dec; 22(12):209-229. PubMed ID: 36374376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]